Banner

Archive for the ‘News’ Category

18e appel à projets FUI : Le projet Screencell “EXPEVIVO2-CTC” labellisé par le pôle de compétitivité Medicen Paris Region

Icon Written by ScreenCell on October 22, 2014 – 4:25 pm

18e appel à projets FUI : 4 projets labellisés par le pôle de compétitivité Medicen Paris Region Les ministres en charge de la politique des pôles de compétitivité, en lien avec les présidents des Conseils régionaux et l’association des Régions de France, ont annoncé le financement de 67 projets sélectionnés lors du 18ème appel à […]



Researchers Use ScreenCell® To Enrich Breast Cancer CTC Biomarkers

Icon Written by ScreenCell on October 22, 2014 – 2:40 pm

Researchers Use Screencell to enrich Breast Cancer CTC Biomarkers Researchers Use ScreenCell® To Enrich Breast Cancer CTC Biomarkers October 22, 2014 07:30 AM Eastern Daylight Time PARIS–(BUSINESS WIRE)–ScreenCell has entered into a collaborative study with the Jefferson Breast Care Center at the Sidney Kimmel Cancer Center of Thomas Jefferson University in Philadelphia, to evaluate the […]



ScreenCell’s devices are dedicated to the research market and are now CE labeled for the extraction from blood of circulating tumor cells for the clinical market in Europe

Icon Written by ScreenCell on September 10, 2014 – 3:28 pm


Researchers Report ScreenCell® Usage for Colorectal Cancer – CTC Biomarker

Icon Written by ScreenCell on August 14, 2014 – 2:17 pm

Researchers Report ScreenCell® Usage for Colorectal Cancer – CTC Biomarker August 12, 2014 08:30 AM Eastern Daylight Time PARIS–(BUSINESS WIRE)–In a recent paper, Cancer Biomarkers (Cancer Biomarkers 14 (2014) p.145–150), researchers at Rouen University Hospital, Rome University Hospital-La Sapienza, and University of Medicine and Pharmacy, Cluj-Napoca, Romania report on the use of the ScreenCell Cyto […]



NYtimes: “Sidestepping the Biopsy With New Tools to Spot Cancer” By Andrew Pollack April 7, 2014

Icon Written by ScreenCell on June 24, 2014 – 2:59 pm

http://www.nytimes.com/2014/04/08/business/cancer-analysis-tools-circumvent-biopsies.html?_r=0  



ScreenCell® Marks Shipment of 50,000 units for Characterization of Circulating Tumor Cells

Icon Written by ScreenCell on June 13, 2014 – 11:21 am

ScreenCell is a fully disposable, self-contained separation device that removes all blood components from CTCs, based on size differential. “We provide a customized solution to research sites that include optimum transportation of patent samples, rapid cell separation, and validated protocols for characterization.” said Georges Uzan, CSO of ScreenCell. ScreenCell’s patented design supports a complete set […]



Paris – ScreenCell today released a white paper that details a “next generation” technology for fast isolation of undamaged fixed cells and viable live circulating tumor cells

Icon Written by ScreenCell on January 15, 2013 – 3:51 pm

ScreenCell offers a white paper on effective circulating tumor cells isolation  Paris– ScreenCell today released a white paper that details a “next generation” technology for fast isolation of undamaged fixed cells and viable live circulating tumor cells. The white paper entitled Rapid and Simple isolation of Circulating Tumor Cells for Clinical and Research Applications using […]



ScreenCell and BioView Announce Worldwide Commercial Collaboration Agreement for Circulating Tumor Cell (CTC) Technology

Icon Written by ScreenCell on July 9, 2012 – 5:15 pm

REHOVOT, Israel and PARIS, July 9, 2012 BioView Ltd. (TASE: BIOV) and ScreenCell, a privately-held company, today jointly announced the signing of a commercial collaboration agreement for Bioview’s Automated Cell Imaging Systems for imaging of CTC’s isolated with ScreenCell’s Cyto Kit ®. Dr. Alan Schwebel, President and CEO of BioView, views this agreement as a unique combination of two innovative […]



Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for Circulating Tumor Cell (CTC) Technology

Icon Written by ScreenCell on May 17, 2012 – 2:58 pm

Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for Circulating Tumor Cell (CTC) Technology Affymetrix releases first CTC platform for 4-color RNA-ISH Combination of ScreenCell’s isolation devices and Affymetrix’ QuantiGene® ViewRNA ISH technology enables easy, accessible, sensitive, multiplex, low-cost system to enumerate and characterize CTCs and other rare cells.   SANTA CLARA,Calif., &PARIS,France– May 17, 2012 […]



Transgenomic and ScreenCell Announce Worldwide Distribution and Collaboration Agreement for Circulating Tumor Cell (CTC) Technology

Icon Written by ScreenCell on November 8, 2011 – 9:30 am

Transgenomic and ScreenCell Announce Worldwide Distribution and Collaboration Agreement for Circulating Tumor Cell (CTC) Technology OMAHA, Neb. & PARIS–(BUSINESS WIRE)–Transgenomic, Inc. (OTC/BB: TBIO) and ScreenCell, a privately- held company, today announced the signing of a perpetual, worldwide collaboration and distribution agreement for ScreenCell’s Isolation Devices and Dilution Buffers, designed for the collection of Circulating Tumor […]